Abstract:Peptides of melanosomal proteins have recently been shown to be recognized in an HLA-restricted mode by specific cytolytic T lymphocytes in melanoma patients. Dendritic antigen-presenting cells (DC) are considered to be the most effective stimulators of T cell responses, and the use of these cells has therefore been proposed to generate therapeutic responses to tumor antigens in cancer patients. We, therefore, generated DC from peripheral blood of normal donors in the presence of granulocyte/macrophage colony-stimulating factor and interleukin-4. Flow cytometric analysis of the cells during a 2-week culture revealed a loss of CD14 and CD34 expression, a concomittent increase of CD1a, CD11a,b and c, CD44, CD45, CD54, HLA-class I and II, and intermediate levels of CD26, CD80 and CD86. Cultured DC stimulated proliferation of allogeneic T cells and induced a marked, up to 20-fold, stimulation of T cell proliferation after pulsing with tetanus toxoid. To achieve independence of already-identified antigenic peptides presented in HLA class I-restricted fashion, which limits the general applicability of such peptides for vaccination of melanoma patients, we tested whether DC are transfectable with eukaryotic expression plasmids. DC transfected with two reporter genes (CAT, beta-galactosidase) using a liposome-based transfection technique, exhibited only low levels of enzymatically active proteins, but were able to degrade rapidly intracellular proteins and to process peptides efficiently. Chloramphenicol acetyltransferase as well as tyrosinase mRNA were detectable after transfection by reverse-transcriptase-polymerase chain reaction, and enzyme activities became measurable. Furthermore, DC transfected with the tyrosinase gene were able to induce specific T cell activation in vitro, indicating appropriate peptide processing and presentation in DC after transfection. These data suggest new approaches to future tumor vaccination strategies.

Mouse fibroblast expressing human tyrosinase with DHICA-oxidase activity produces predominantly pheomelanin deposit in lysosome

Lipocalin-type Prostaglandin D Synthase As a Melanocyte Marker Regulated by MITF.

Tyrosinase Depletion Prevents the Maturation of Melanosomes in the Mouse Hair Follicle

Establishment of a synchronized tyrosinase transport system revealed a role of Tyrp1 in efficient melanogenesis by promoting tyrosinase targeting to melanosomes

Diacylglycerol kinase regulates tyrosinase expression and function in human melanocytes

MITF-M regulates melanogenesis in mouse melanocytes

The tyrosinase enhancer is activated by Sox10 and Mitf in mouse melanocytes

Purified Mushroom Tyrosinase Induced Melanogenic Protein Expression in B16F10 Melanocytes: A Quantitative Densitometric Analysis

Membrane-Associated Ubiquitin Ligase RING Finger Protein 152 Orchestrates Melanogenesis via Tyrosinase Ubiquitination

Use of non-melanocytic HEK293 cells stably expressing human tyrosinase for the screening of anti-melanogenic agents

Ectopic expression of tyrosinase increases melanin synthesis and cell death following UVB irradiation in fibroblasts from familial atypical multiple mole and melanoma (FAMMM) patients

Characterization of a new, inducible transgenic mouse model with GFP expression in melanocytes and their precursors

Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation

MFSD12 mediates the import of cysteine into melanosomes and lysosomes

Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations

Tyrosinase:Recent Prospects

Expression of Melanin-Related Genes in Cultured Adult Human Retinal Pigment Epithelium and Uveal Melanoma Cells.

“Transcription physiology” of pigment formation in melanocytes: central role of MITF

Syntenin regulates melanogenesis via the p38 MAPK pathway

Peptide and peptidomimetic tyrosinase inhibitors

Debut of a novel AIE-based fluorescent probe as tyrosinase tracer to image skin pigmentary disorders